Cornerstone Planning Group
LABU icon

Cornerstone Planning Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Cornerstone Planning Group’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-36
Closed -$9.03K – 1008
2026
Q2 		$9.03K Hold
36
– – ﹤0.01% 921
2026
Q1 		$6.66K Hold
36
– – ﹤0.01% 1017
2025
Q4 		$6.08K Sell
36
-1,791
-98% -$246K ﹤0.01% 925
2025
Q3 		$204K Buy
1,827
+1,792
+5,120% +$127K 0.03% 134
2025
Q2 		$2.25K Hold
35
– – ﹤0.01% 909
2025
Q1 		$1.86K Hold
35
– – ﹤0.01% 1003
2024
Q4 		$3.36K Hold
35
– – ﹤0.01% 665
2024
Q3 		$4.41K Sell
35
-1
-3% -$130 ﹤0.01% 590
2024
Q2 		$3.96K Hold
36
– – ﹤0.01% 623
2024
Q1 		$3.83K Buy
36
+1
+3% +$131 ﹤0.01% 559
2023
Q4 		$4.27K Hold
35
– – ﹤0.01% 548
2023
Q3 		$2.67K Hold
35
– – ﹤0.01% 608
2023
Q2 		$4.15K Buy
+35
New +$4.36K ﹤0.01% 952
2022
Q4 		$4.47K Buy
+30
New +$4.18K ﹤0.01% 945

Other funds holding LABU

Halbert Hargrove Global Advisors
Halbert Hargrove Global Advisors Long Beach, California $2.29B AUM 13.62% 1-Year Est. Return
Mather Group
Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return

Cornerstone Planning Group's LABU Position: Q3 2026 in Review

Cornerstone Planning Group sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2026, closing a stake of 36 shares — an estimated $9.03K sold.

Cornerstone Planning Group first reported a position in LABU in Q4 2022 and held it in 14 quarters. The position peaked at $204K in Q3 2025. 2 funds tracked by Wall St. Rank hold LABU as of Q3 2026.

  • Cornerstone Planning Group reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 36 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2026, an estimated $9.03K.
  • Cornerstone Planning Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2022 and held it in 14 quarters.
  • Cornerstone Planning Group's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $204K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.